FERTIG; GEORG
Patent Applications and Registrations
Patent applications and USPTO patent grants for FERTIG; GEORG.The latest application filed is for "antibodies binding to gprc5d".
Company Profile
8.40.47
- FERTIG; GEORG - Penzberg DE
Patent Activity
| Patent | Date |
|---|---|
| Bispecific Antibodies Specific For Pd1 And Tim3 App 20220259314 - CODARRI-DEAK; LAURA ; et al. | 2022-08-18 |
| Antibodies Binding To Gprc5d App 20220259318 - BUJOTZEK; ALEXANDER ; et al. | 2022-08-18 |
| Bispecific antibodies specific for PD1 and TIM3 Grant 11,130,810 - Codarri-Deak , et al. September 28, 2 | 2021-09-28 |
| Antibodies Binding To Gprc5d App 20210054094 - FERTIG; GEORG ; et al. | 2021-02-25 |
| Cellular based fret assay for the determination of simultaneous binding Grant 10,718,762 - Seeber , et al. | 2020-07-21 |
| Bispecific Antibodies Specific For Pd1 And Tim3 App 20190322748 - CODARRI-DEAK; LAURA ; et al. | 2019-10-24 |
| Antibodies Against Human Csf-1r And Uses Thereof App 20190300614 - DIMOUDIS; Nikolaos ; et al. | 2019-10-03 |
| Antibodies against human CSF-1R and uses thereof Grant 10,336,830 - Fertig , et al. | 2019-07-02 |
| Antibodies against human CSF-1R and uses thereof Grant 10,287,358 - Dimoudis , et al. | 2019-05-14 |
| Bispecific antibodies specific for PD1 and TIM3 Grant 10,287,352 - Codarri-Deak , et al. | 2019-05-14 |
| Antibodies Against Human Csf-1r And Uses Thereof App 20190071507 - DIMOUDIS; Nikolaos ; et al. | 2019-03-07 |
| Antibodies Against Human Csf-1r And Uses Thereof App 20180346582 - Fertig; Georg ; et al. | 2018-12-06 |
| Cellular Based Fret Assay For The Determination Of Simultaneous Binding App 20180328920 - SEEBER; Stefan ; et al. | 2018-11-15 |
| Antibodies against human CSF-1R and uses thereof Grant 10,077,314 - Dimoudis , et al. September 18, 2 | 2018-09-18 |
| Antibodies against human CSF-1R and uses thereof Grant 10,072,087 - Dimoudis , et al. September 11, 2 | 2018-09-11 |
| Antibodies Against Human Csf-1r And Uses Thereof App 20180244788 - DIMOUDIS; Nikolaos ; et al. | 2018-08-30 |
| Antibodies Against Human Csf-1r And Uses Thereof App 20180208662 - DIMOUDIS; Nikolaos ; et al. | 2018-07-26 |
| Antibodies against human CSF-1R and uses thereof Grant 10,030,073 - Fertig , et al. July 24, 2 | 2018-07-24 |
| Antibodies against human CSF-1R and uses thereof Grant 10,023,643 - Fertig , et al. July 17, 2 | 2018-07-17 |
| Antibodies against human CSF-1R and uses thereof Grant 9,988,458 - Fertig , et al. June 5, 2 | 2018-06-05 |
| Antibodies against human CSF-1R and uses thereof Grant 9,879,085 - Dimoudis , et al. January 30, 2 | 2018-01-30 |
| Antibodies Against Human Csf-1r And Uses Thereof App 20170320953 - DIMOUDIS; Nikolaos ; et al. | 2017-11-09 |
| Antibodies Against Human Csf-1r And Uses Thereof App 20170275368 - FERTIG; Georg ; et al. | 2017-09-28 |
| Antibodies against human CSF-1R and uses thereof Grant 9,663,580 - Dimoudis , et al. May 30, 2 | 2017-05-30 |
| Antibodies Against Human Csf-1r And Uses Thereof App 20170114139 - FERTIG; Georg ; et al. | 2017-04-27 |
| Bispecific Antibodies Specific For Pd1 And Tim3 App 20170114135 - CODARRI-DEAK; LAURA ; et al. | 2017-04-27 |
| Nucleic acids encoding antibodies against human CSF-1R Grant 9,624,302 - Fertig , et al. April 18, 2 | 2017-04-18 |
| Nucleic acids encoding antibodies against human CSF-1R and uses thereof Grant 9,617,342 - Fertig , et al. April 11, 2 | 2017-04-11 |
| Antibodies Against Human Csf-1r And Uses Thereof App 20170029517 - DIMOUDIS; Nikolaos ; et al. | 2017-02-02 |
| Antibodies Against Human Csf-1r And Uses Thereof App 20170015752 - FERTIG; Georg ; et al. | 2017-01-19 |
| Antibodies against human CSF-1R and uses thereof Grant 9,499,626 - Dimoudis , et al. November 22, 2 | 2016-11-22 |
| Antibodies against human CSF-1R and uses thereof Grant 9,499,624 - Dimoudis , et al. November 22, 2 | 2016-11-22 |
| Antibodies against human CSF-1R and uses thereof Grant 9,499,625 - Dimoudis , et al. November 22, 2 | 2016-11-22 |
| Antibodies against human IL33R and uses thereof Grant 9,309,319 - Fertig , et al. April 12, 2 | 2016-04-12 |
| Antibodies Against Human Csf-1r And Uses Thereof App 20160053015 - FERTIG; Georg ; et al. | 2016-02-25 |
| Combination Therapy Of A Type Ii Anti-cd20 Antibody With A Proteasome Inhibitor App 20160000912 - FERTIG; GEORG ; et al. | 2016-01-07 |
| Antibodies against human CSF-1R Grant 9,221,910 - Fertig , et al. December 29, 2 | 2015-12-29 |
| Antibodies against human CSF-1R Grant 9,169,323 - Fertig , et al. October 27, 2 | 2015-10-27 |
| Antibodies Against Human Csf-1r And Uses Thereof App 20150274830 - DIMOUDIS; Nikolaos ; et al. | 2015-10-01 |
| Antibodies Against Human Csf-1r And Uses Thereof App 20150274831 - DIMOUDIS; Nikolaos ; et al. | 2015-10-01 |
| Antibodies Against Human Csf-1r And Uses Thereof App 20150175696 - FERTIG; Georg ; et al. | 2015-06-25 |
| Antibodies Against Human Csf-1r And Uses Thereof App 20150158950 - DIMOUDIS; Nikolaos ; et al. | 2015-06-11 |
| Antibodies against human CSF-1R and uses thereof Grant 8,999,327 - Dimoudis , et al. April 7, 2 | 2015-04-07 |
| Antibodies Against Human Csf-1r And Uses Thereof App 20150080556 - FERTIG; Georg ; et al. | 2015-03-19 |
| Antibodies Against Human Csf-1r And Uses Thereof App 20140336363 - Fertig; Georg ; et al. | 2014-11-13 |
| Antibodies against CDCP1 for the treatment of cancer Grant 8,883,159 - Bossenmaier , et al. November 11, 2 | 2014-11-11 |
| Antibodies Against Human Il33r And Uses Thereof App 20140302015 - Fertig; Georg ; et al. | 2014-10-09 |
| Antibodies against human IL33R and uses thereof Grant 8,785,153 - Fertig , et al. July 22, 2 | 2014-07-22 |
| Antibodies Against Human Csf-1r And Uses Thereof App 20130005949 - Fertig; Georg ; et al. | 2013-01-03 |
| Antibodies Against Human Csf-1r And Uses Thereof App 20120329997 - Fertig; Georg ; et al. | 2012-12-27 |
| Combination therapy of a type II anti-CD20 antibody with a proteasome inhibitor App 20120219549 - Fertig; Georg ; et al. | 2012-08-30 |
| Antibodies against human IL33R and uses thereof App 20120213774 - Fertig; Georg ; et al. | 2012-08-23 |
| Combination Therapy Of A Type Ii Anti-cd20 Antibody With A Proteasome Inhibitor App 20110200598 - Fertig; Georg ; et al. | 2011-08-18 |
| Antibodies Against Human Csf-1r And Uses Thereof App 20110165156 - DIMOUDIS; NIKOLAOS ; et al. | 2011-07-07 |
| Antibodies Against CDCP1 for the Treatment of Cancer App 20110070246 - Bossenmaier; Birgit ; et al. | 2011-03-24 |
| Combination Therapy Of An Afucosylated Antibody And One Or More Of The Cytokines Gm Csf, M Csf And/or Il3 App 20100247484 - BARCHET; HEINRICH ; et al. | 2010-09-30 |
| Determination of apoptotic products in tumor patients undergoing therapy Grant 7,759,071 - Holdenrieder , et al. July 20, 2 | 2010-07-20 |
| Hydroxamates, their manufacture and use as pharmaceutical agents Grant 7,638,553 - Fertig , et al. December 29, 2 | 2009-12-29 |
| Antibodies Against Interleukin-1 Receptor And Uses Thereof App 20090191187 - Bartke; Ilse ; et al. | 2009-07-30 |
| Combination Therapy Of Type Ii Anti-cd20 Antibody With A Proteasome Inhibitor App 20090110688 - FERTIG; GEORG ; et al. | 2009-04-30 |
| Mono-acylated o-phenylendiamines derivatives Grant 7,501,451 - Fertig , et al. March 10, 2 | 2009-03-10 |
| Thiophene hydroxamic acid derivatives and their use as HDAC inhibitors Grant 7,423,060 - Fertig , et al. September 9, 2 | 2008-09-09 |
| Thiophene derivatives, their manufacture and use as pharmaceutical agents Grant 7,396,944 - Fertig , et al. July 8, 2 | 2008-07-08 |
| Hydroxamates, Their Manufacture And Use As Pharmaceutical Agents App 20080139640 - Fertig; Georg ; et al. | 2008-06-12 |
| Determination Of Apoptotic Products In Tumor Patients Undergoing Therapy App 20080108094 - HOLDENRIEDER; Stefan ; et al. | 2008-05-08 |
| Thiophene Hydroxamic Acid Derivatives and Their Use as Hdac Inhibitors App 20080070976 - Fertig; Georg ; et al. | 2008-03-20 |
| Thiophene Derivatives, Their Manufacture and Use as Pharmaceutical Agents App 20070232602 - Fertig; Georg ; et al. | 2007-10-04 |
| Detection of apoptotic products Grant 7,229,772 - Holdenrieder , et al. June 12, 2 | 2007-06-12 |
| N-monoacylated o-phenylenediamines Grant 7,208,491 - Fertig , et al. April 24, 2 | 2007-04-24 |
| Oxime derivatives and their use as pharmaceutically active agents Grant 7,173,060 - Fertig , et al. February 6, 2 | 2007-02-06 |
| Arylene-carboxylic acid (2-amino-phenyl)-amide derivatives Grant 7,098,247 - Fertig , et al. August 29, 2 | 2006-08-29 |
| Mono-acylated o-phenylendiamines derivatives Grant 7,071,219 - Fertig , et al. July 4, 2 | 2006-07-04 |
| Mono-acylated o-phenylendiamines derivatives App 20060089403 - Fertig; Georg ; et al. | 2006-04-27 |
| 2-(2,6-Dichlorophenyl)-Diarylimidazoles Grant 6,946,471 - Brandt , et al. September 20, 2 | 2005-09-20 |
| Antibodies against interleukin-1 receptor and uses thereof App 20050118169 - Bartke, Ilse ; et al. | 2005-06-02 |
| Oxime derivatives and their use as pharmaceutically active agents App 20040214880 - Fertig, Georg ; et al. | 2004-10-28 |
| 2-(2,6-dichlorophenyl)-diarylimidazoles Grant 6,790,852 - Brandt , et al. September 14, 2 | 2004-09-14 |
| Mono-acylated o-phenylendiamines derivatives App 20040162317 - Fertig, Georg ; et al. | 2004-08-19 |
| N-monoacylated o-phenylenediamines App 20040157841 - Fertig, Georg ; et al. | 2004-08-12 |
| Novel arylene-carboxylic acid (2-amino-phenyl)-amide derivatives App 20040138270 - Fertig, Georg ; et al. | 2004-07-15 |
| 2-(2,6-dichlorophenyl)-diarylimidazoles App 20030199691 - Brandt, Michael ; et al. | 2003-10-23 |
| Method And Reagent For The Detection Of Apoptotic Cells And Of A Protease Activated During Apoptosis App 20020012945 - FERTIG, GEORG | 2002-01-31 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 